CRIS Current Research Information System

MIGLIOLI, MARIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 3.373
NA - Nord America 2.985
EU - Europa 1.747
SA - Sud America 288
AF - Africa 158
OC - Oceania 2
Totale 8.553
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.921
SG - Singapore 1.042
VN - Vietnam 814
CN - Cina 726
HK - Hong Kong 355
SE - Svezia 289
GB - Regno Unito 278
IT - Italia 268
BR - Brasile 231
DE - Germania 226
FR - Francia 131
RU - Federazione Russa 108
IN - India 97
IE - Irlanda 88
NL - Olanda 84
UA - Ucraina 69
JP - Giappone 67
KR - Corea 62
BG - Bulgaria 56
FI - Finlandia 45
SC - Seychelles 42
CI - Costa d'Avorio 41
BD - Bangladesh 39
CA - Canada 34
CH - Svizzera 29
AR - Argentina 28
JO - Giordania 26
TG - Togo 26
ZA - Sudafrica 25
ID - Indonesia 20
PH - Filippine 19
MX - Messico 18
PL - Polonia 18
TH - Thailandia 17
PK - Pakistan 12
ES - Italia 11
IQ - Iraq 11
IR - Iran 11
BE - Belgio 10
AT - Austria 9
EE - Estonia 9
TR - Turchia 9
EC - Ecuador 7
SA - Arabia Saudita 7
TW - Taiwan 7
UZ - Uzbekistan 7
BH - Bahrain 6
CL - Cile 6
KE - Kenya 6
MY - Malesia 6
CO - Colombia 5
RO - Romania 5
NG - Nigeria 4
NP - Nepal 4
PY - Paraguay 4
DO - Repubblica Dominicana 3
EG - Egitto 3
GR - Grecia 3
LT - Lituania 3
PE - Perù 3
BA - Bosnia-Erzegovina 2
GT - Guatemala 2
JM - Giamaica 2
MA - Marocco 2
MD - Moldavia 2
OM - Oman 2
TN - Tunisia 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
AZ - Azerbaigian 1
BB - Barbados 1
BF - Burkina Faso 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
CU - Cuba 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
ET - Etiopia 1
IL - Israele 1
IS - Islanda 1
KG - Kirghizistan 1
KZ - Kazakistan 1
MU - Mauritius 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
SK - Slovacchia (Repubblica Slovacca) 1
SO - Somalia 1
SR - Suriname 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
VE - Venezuela 1
Totale 8.553
Salva come PNG Salva come JPEG
Città #
Singapore 682
Hong Kong 339
San Jose 320
Ashburn 308
Chandler 287
Santa Clara 253
Ho Chi Minh City 221
Southend 203
Hanoi 187
Boardman 122
Beijing 110
Fairfield 104
Princeton 97
Hefei 95
Dublin 88
New York 65
Los Angeles 63
Sofia 52
Ann Arbor 51
Houston 50
Tokyo 50
Wilmington 49
Lauterbourg 47
Seoul 46
Woodbridge 46
Berlin 43
Helsinki 43
Cambridge 42
Abidjan 41
Jacksonville 41
Seattle 37
Frankfurt am Main 33
Da Nang 30
Haiphong 29
Bern 28
São Paulo 28
Guangzhou 27
Amman 26
Buffalo 26
Lomé 26
Milan 26
Bologna 25
Dong Ket 24
Falkenstein 24
Nanjing 23
Dallas 21
Council Bluffs 18
Shanghai 18
Turin 18
Rome 17
San Francisco 17
Chicago 16
Padova 16
Westminster 16
Orem 15
Redondo Beach 14
Warsaw 14
Bengaluru 12
Mumbai 12
Boston 11
Denver 11
Hải Dương 11
Montreal 11
Brussels 10
Chennai 10
Jinan 10
London 10
Poplar 10
San Diego 10
Wuhan 10
Xi'an 10
Biên Hòa 9
Can Tho 9
Changsha 9
Columbus 9
Düsseldorf 9
Hangzhou 9
Johannesburg 9
Mexico City 9
Nuremberg 9
Phoenix 9
Shijiazhuang 9
Yubileyny 9
Amsterdam 8
Bari 8
Curitiba 8
Kyiv 8
Lahore 8
Munich 8
Naples 8
Olalla 8
Vũng Tàu 8
Zhengzhou 8
Belo Horizonte 7
Mountain View 7
Mülheim 7
Nanchang 7
Salt Lake City 7
Shenyang 7
Shenzhen 7
Totale 5.142
Salva come PNG Salva come JPEG
Nome #
5-Aminosalicylic acid in patients with ulcerative colitis in remission: plasma levels after administration of a new rectal enema 275
Reversibility of GERD ultrastructural alterations and relief of symptoms after omeprazole treatment 260
5-Aminosalicylic acid suppositories in the management of ulcerative colitis 255
Erosions or not in GORD? The potential role of oesophageal cell proliferation 245
Effetti avversi gastrointestinali: farmaci anti-infiammatori non steroidei ed Helicobacter pylori 237
Effect of omeprazole on symptoms and ultrastructural esophageal damage in acid bile reflux 219
Epidemiologia dell’Infezione da Helicobacter pylori e Cancro gastrico non cardiale. Insegnamenti per il futuro. 215
Diagnosi non invasiva e terapia per Helicobacter Pylori 206
Cell proliferation and ultrastructural changes of the duodenal mucosa of patients affected by familial adenomatous polyposis. 205
Effect of Proton Pump Inhibitors and Antacid Therapy on 13C-Urea Breath Tests and Stool Test for Helicobacter pylori Infection 200
A Rapid Immunochromatographic Assay for Helicobacter pylori in Stool before and after Treatment 199
Erosions or not in GERD? The potential role of esophageal cell kinetics 189
Diagnosi dell’infezione da Helicobacter pylori 180
Italian guidelines for intestinal transplantation: potential candidates among the adult patients managed by a medical referral center for chronic intestinal failure. 179
Three-year experience in clinical intestinal transplantation 174
The SF-36 instrument for the follow-up of health-related quality-of-life assessment of patients undergoing home parenteral nutrition for benign disease. 169
Peptic ulcer and Helicobacter pylori. 159
Superoxide dismutase expression in gastric adenocarcinoma: a clinical biomarker in the development of cancer. 139
Long-term efficacy of bismuth carbomer enemas in patients with treatment-resistant chronic pouchitis 120
Effects of new fish oil derivative on fatty acid phospholipid-membrane pattern in a group of Crohn's disease patients 118
Changes in splanchnic hemodynamics in inflammatory bowel disease non-invasive assessment by doppler ultrasound flowmetry 108
Bioavailability of single and multiple doses of a new oral formulation of 5‐ASA in patients with inflammatory bowel disease and healthy volunteers 108
Respiratory burst of circulating polymorphonuclear leukocytes and plasma elastase levels in patients with inflammatory bowel disease in remission 106
Interleukin 1 in ulcerative colitis 106
Retrograde colonic spread of a new mesalazine rectal enema in patients with distal ulcerative colitis 106
Optimum dosage of 5-Aminosalicylic acid as rectal enemas in patients with active ulcerative colitis 105
5-Aminosalicylic acid as enemas or suppositories in distal ulcerative colitis? 104
Placebo-controlled trial of oral 5-ASA in relapse prevention of Crohn's disease 103
Role of rectal formulations: Enemas 100
Scavenger effect of sulphasalazine (SASP), 5-aminosalicylic acid (5-ASA), and olsalazine (OAZ) (I) 100
Enhanced mucosal interleukin-6 and -8 in Helicobacter pylori-positive dyspeptic patients 97
Macrophage subpopulations in pouchitis 97
Bronchopulmonary involvement in ulcerative colitis 97
Scavenger effect of sulfasalazine, 5-aminosalicylic acid, and olsalazine on superoxide radical generation 95
Comparison of oral with rectal mesalazine in the treatment of ulcerative proctitis 94
Lack of effect of antineutrophil cytoplasmic antibodies associated with ulcerative colitis on superoxide anion production from neutrophils 94
Short report: zinc sulphate supplementation corrects abnormal erythrocyte membrane long‐chain fatty acid composition in patients with Crohn's disease 93
Interleukin 1 beta (IL-1 beta) release from fresh and cultured colonic mucosa in patients with ulcerative colitis (UC) 91
Efficacy of 5-aminosalicylic acid enemas versus hydrocortisone enemas in ulcerative colitis 91
Topical treatment with 5-aminosalicylic in distal ulcerative colitis by using a new suppository preparation - A double-blind placebo controlled trial 90
Pentasa in maintenance treatment of ulcerative colitis 89
Intracolonic release of nitric oxide during trinitrobenzene sulfonic acid rat colitis 89
Requirements for the use of intestinal action antibiotics in the treatment of ulcerative colitis 89
Mucosal concentrations of interleukin-1β, interleukin-6, interleukin-8, and tumor necrosis factor-α in pelvic ileal pouches 87
Spread and distribution of 5-ASA colonic foam and 5-ASA enema in patients with ulcerative colitis 83
Systemic availability of 5-aminosalicylic acid: Comparison of delayed release and an azo-bond preparation 80
The clinical role of stool test (HpSA) in noninvasive diagnosis of Helicobacter pylori infection 73
Helicobacter pylori and diminished growth in children: Is it simply a marker of deprivation? 72
Rifaximin suspension for the eradication of helicobacter pylori 72
Helicobacter pylori in Patients with Gastric and Nongastric Cancer 70
Non-invasive analyses for the diagnosis of Helicobacter pylori infection. A critical review of the literature 70
A rapid, low-dose, 13C-urea tablet for the detection of Helicobacter pylori infection before and after treatment 63
Gastric retention of sucralfate gel and suspension in upper gastrointestinal diseases 62
Helicobacter pylori in Patients with Gastric and Nongastric Cancer 57
Folic acid supplementation and cell kinetics of rectal mucosa in patients with ulcerative colitis 57
Antimicrobial activity of esomeprazole versus omeprazole against Helicobacter pylori 56
Peptic ulcer and Helicobacter pylori: Update on testing and treatment 56
The clinical role of cytochrome P450 genotypes in Helicobacter pylori management 55
High eradication rates of Helicobacter pylori with a new sequential treatment 53
High eradication rates of Helicobacter pylori with a new sequential treatment 52
The clinical role of stool test (HpSA) in noninvasive diagnosis of Helicobacter pylori infection 52
Helicobacter pylori status, endoscopic findings, and serology in HIV-1-positive patients 48
A clinical study of gastric emptying and bioadhesitivity of two forms of sucralfate 44
Helicobacter pylori status, endoscopic findings, and serology in HIV-1-positive patients 43
Rectal cell proliferation and colon cancer risk in patients with hypergastrinaemia 43
Lipid peroxidation and antioxidant status in adults receiving lipid- based home parenteral nutrition 43
Spectrotypic analysis of antibodies to Helicobacter pylori in patients with antral gastritis and duodenal ulcer 42
Review article: Diagnosis and treatment of Helicobacter: A 2002 updated review 41
Helicobacter pylori, diagnosis and treatment after 10 years of its discovery 40
Hypersensitivity of gastric parietal cells to selective H2-receptor stimulation in duodenal ulcer 40
Endoscopic findings in 288 asymptomatic blood donors according to high levels of IgG to helicobacter pylori 40
Review article: Invasive and non-invasive tests for Helicobacter pylori infection 39
Diagnostic accuracy of a new rapid urease test (Pronto Dry) before and after treatment of Helicobacter pylori infection 37
Clinical aspects of serology in the diagnosis of Helicobacter pylori infection 37
Therapeutics news on Helicobacter pylori and clarithromycin from Budapest, Wien and Helsinki 36
Review article: Helicobacter pylori infection from pathogenesis to treatment - A critical reappraisal 36
Review article: Diagnosis of Helicobacter pylori infection 32
Susceptibility of Helicobacter pylori to Metronidazole 31
Prospective screening of dyspeptic patients by Helicobacter pylori serology: A safe policy? 30
Clinical significance of helicobacter pylori seropositivity and seronegativity in asymptomatic blood donors 30
Effect of Helicobacter pylori eradication on development of dyspeptic and reflux disease in healthy asymptomatic subjects 29
Routes of trasmission of Helicobacter pylori infection 29
A second-line anti-Helicobacter pylori therapy in patients with previously failed treatment [7] 28
Optimal nutritional indexes in gastroenterology 28
Anti-CagA reactivity in Helicobacter pylori-negative subjects: A comparison of three different methods 27
Source of Helicobacter pylori Infection 26
Circadian rhythm of gastric inhibitory polypeptide (GIP) in man 26
Low levels of essential fatty acids in the red blood cell membrane phospholipid fraction of long-term home parenteral nutrition patients [1] 26
Symptoms and Helicobacter pylori: Any link [6] 25
Lactose Malabsorption in Adult Patients with Crohn's Disease 25
Clinical role of fecal antigen determination in the diagnosis of Helicobacter pylori infection 24
Biliary surgery without the surgeon! 23
Prospective screening of dyspeptic patients by Helicobacter pylori serology: A safe policy? 22
Therapeutic news on Helicobacter pylori from Budapest and Wien 22
Comparison of urease tests for the diagnosis of Helicobacter pylori infection 22
Diagnosis of Helicobacter pylori infection: Which is the best test? The stool test 22
Therapeutic news on Helicobacter pylori from Budapest and Wien 20
Treatment of symptom-free Helicobacter pylori-positive subjects 20
Helicobacter pylori: Diseases, tests and treatment 19
Helicobacter pylori seroconversion in asymptomatic blood donors: A five-year follow-up 19
Totale 8.579
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.848
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.848
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202147 0 0 0 0 0 0 0 0 0 0 0 47
2021/2022687 19 12 30 34 36 14 4 25 125 71 207 110
2022/20231.024 109 172 88 84 69 80 28 69 182 21 50 72
2023/2024444 96 66 30 60 32 83 12 23 3 23 7 9
2024/20251.795 59 189 131 100 402 88 130 69 27 135 55 410
2025/20263.894 296 308 344 287 404 208 279 262 844 375 142 145
Totale 8.710